Cardiac Biomarker Diagnostic Test Kits Market
Market Insights on Cardiac Biomarker Diagnostic Test Kits covering sales outlook, demand forecast & up-to-date key trends
Cardiac Biomarker Diagnostic Test Kits Market by Product Type (Brain Natriuretic Peptide (BNPs) Test Kits, Creatine Kinase MB (CK-MB) Test Kits, Troponin (I&T) Tests Kits, Myoglobin Test Kits), Indication (Angina Pectoris, Acute Myocardial Infarction, Congestive Heart Failure), End Users & Region for 2022-2028
Cardiac Biomarker Diagnostic Test Kits Market Snapshot
[239 Pages Report] The global Cardiac Biomarker Diagnostic Test Kits Market is slated to top US$ 1.8 Bn by the end of 2022, estimates Future Market Insights (FMI). With growing prevalence of cardiac diseases, the overall market is projected to expand at 5.1% CAGR over the forecast period, from 2022 to 2028.
As per the study, sales of brain natriuretic peptide (BNPs) test kits is expected to contribute over half of demand in Cardiac Biomarker Diagnostic Test Kits Market. Demand for BNP test kits is expected to increase on the back of rising incidence of heart failure, coupled with increasing need for cardiac biomarkers to curb the growing burden of cardiovascular ailments.
|
Attribute |
Details |
|
Cardiac Biomarker Diagnostic Test Kits Market Size Value in 2021 |
US$ 1.8 Billion |
|
Cardiac Biomarker Diagnostic Test Kits Market Size Value in 2028 |
US$ 2.5 Billion |
|
North America Cardiac Biomarker Diagnostic Test Kits Market Value in 2021 |
US$ 522.5 Million |
|
CAGR (2021-2028) |
~5.1% |
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
5.10% |
|
H1, 2022 Projected |
5.06% |
|
H1, 2022 Outlook |
4.66% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 40 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 44 ↓ |
According to Future Market Insights analysis, the global cardiac biomarker diagnostic test kits market is expected to drop by 44 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 projected value, the market during H1-2022 outlook period will show a dip of 40 BPS.
Cardiovascular (CV) illness has been diagnosed using a number of cardiac markers. However, there is still a need to search for more modern, more precise molecules due to a lack of sensitivity and specificity to cardiac muscle necrosis. Thus, the dip in the BPS value is associated with - the chances of a false diagnosis and lack of cardiac specificity.
Moreover, cardiac biomarkers pose limitations which also include the high volumes of screen failure due to biomarkers. Additionally, because not every clinical trial site tests every biomarker, the availability of biomarker assays can vary. Additionally, there may be intra- and inter-lab variability due to the use of various tests at various locations.
The methods for evaluating biomarkers may also vary across regional labs and local laboratories in use by different sites. There also exists the need to establish alternative biological sources of the biomarker in use.
All these limitations will be expected to present the above mentioned dip in the BPS values for the cardiac biomarker diagnostic test kits market.
As per the study, sales of brain natriuretic peptide (BNPs) test kits is expected to contribute over half of demand in Cardiac Biomarker Diagnostic Test Kits Market. Demand for BNP test kits is expected to increase on the back of rising incidence of heart failure, coupled with increasing need for cardiac biomarkers to curb the growing burden of cardiovascular ailments.
2022-2028 Cardiac biomarker diagnostic test kits Market Outlook in Comparison to 2013-2021 Growth
The global cardiac biomarker diagnostic test kits market is estimated to be valued at US$ 1.8 Bn in 2022, opines Future Market Insights. The overall demand for cardiac biomarker diagnostic test kits solutions is slated to rise at 5.1% CAGR between 2022 and 2028.
Increasing prevalence of cardiovascular diseases across the globe is the primary factor propelling the growth in the cardiac biomarker diagnostic test kits market. Growing rate of coronary heart disease, congestive heart failure, and angina pectoris is expected to fuel the demand for brain natriuretic peptide (BNP) test kits.
As per the study, sales of BNP test kits are expected to increase at 6.8% CAGR over the forecast period. Demand for BNP test kits are expected to increase at an exceptional rate on the back of rising incidence of congestive heart failure across the U.S., India, and China.
Hence, to curb the growing burden of such cardiovascular diseases, sales of cardiac biomarker diagnostic test kits are expected to reach more than US$ 2.5 Bn by the end of 2028.
How is Expansion of Healthcare Industry Affecting Cardiac Biomarker Diagnostic Test Kit Sales?
Following the outbreak of COVID-19, government across the globe are undertaking several initiatives to improve the healthcare infrastructure. Increasing healthcare expenditure, especially across emerging economies such as India, South Korea, and Japan have also increased the demand for advanced medical devices such as cardiac biomarkers diagnostic test kits.
For instance, as per India Brand Equity Foundation (IBEF), the Government of India approved continuation of ‘National Health Mission’ with a budget of US$ 5.10 billion under the Union Budget of 2021-22.
As per this policy, the government will supply advanced medical devices in rural areas for cardiology, neurology, and other diseases to reduce the global mortality burden. A slew of such initiatives across the globe is expected to create growth opportunities for the market.
Further, with such favorable government initiatives, health professionals and private organizations are introducing and establishing diagnostic laboratories, collaborating with leading players such as Abbot Laboratories and others to cater to the growing demand.
This is expected to increase the sales of cardiac biomarker diagnostics test kits across the globe.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCardiac Biomarker Diagnostic Test Kits Market - Country-wise Analysis
Will India Cardiac Biomarker Diagnostic Test Kits Market Emerge Lucrative in South Asia?
As per the study, sales of cardiac biomarker diagnostic test kits in India are projected to expand at a significant rate over the forecast period. Growth in the region is driven by rising prevalence of obesity in the country resulting in several cardiovascular diseases.
According to the World Health Organization, around 4.77 million people in India suffered from cardiovascular diseases and around 3.1% population suffered from angina pectoris due to obesity.
To curb the burden of growing disease, Government of India is undertaking various initiatives to increase the awareness in rural areas.
For instance, in June 2021, the government introduced funds and self-service healthcare ATMs in rural areas that provides medical testing for cardiology, neurology, and others.
Against this backdrop, several government and private healthcare institutes and diagnostic laboratories are adopting cardiac biomarkers diagnostic test kits to cater to the growing patient pool.
Why is the Demand for Cardiac Biomarker Diagnostic Test Kits Surging in the U.S.?
Chest pain is a common emergency department in the U.S. accounting for 8-10 million visits every year, as per the statistics of the Center for Disease Control and Prevention. Growing incidence of cardiovascular diseases and rising rate of obesity in the country is the primary factor driving the demand in the market.
According to World Health Organization, increasing population with obesity have a higher risk of developing cardiovascular diseases, which is creating growth opportunities for cardiac biomarker diagnostic test kits market in the U.S.
As per Future Market Insights, in terms of value, the U.S. market is expected to account for over 1/3rd of global market by the end of 2028.
How will Brazil Cardiac Biomarker Diagnostic Test Kits Market Fare?
FMI estimates, the market in Latin America is expected to witness sluggish growth through 2021 on the back of low awareness regarding the benefits of cardiac biomarker diagnostic test kits market.
However, with increasing prevalence of cardiovascular diseases in Brazil, demand for these diagnostic test kits are expected to burgeon over the years. As per WHO, mortality rate due to heart failure is increasing, accounting for over 15.60% of total deaths in the country.
In order to reduce the growing rate, government and healthcare organizations are undertaking preventive measures to educate the people regarding the benefits of these test kits. Hence, based on the aforementioned factors, demand for cardiac biomarker diagnostic test kits market in Brazil is expected to surge through 2028.
Cardiac Biomarker Diagnostic Test Kits Market - Category-wise Insights
Why are Brain Natriuretic Peptide (BNPs) Cardiac Biomarker Diagnostic Test Kits Highly Sought-After?
On the basis of product type, the BNP test kit segment is expected to hold lion’s share. As per the study, the segment is expected to account for over 50% of the global market share, with sales estimated to total US$ 682.9 Mn in 2022.
BNP test kits are mostly preferred for the detection of heart failure. With rising incidence of heart failure across the globe among baby boomers and millennials, demand for BNP test kits is expected to increase over the coming years.
On account of this, FMI estimates, sales of BNP test kits in cardiac biomarker diagnostic test kits market are projected to increase at nearly 6.8% CAGR over the forthcoming decade.
Will Rising Incidence of Angina Pectoris Propel the Sales in the Market?
Based on incidence, the angina pectoris segment is expected to be the most lucrative segment in terms of market share. Sales of cardiac biomarker diagnostic test kit due to angina pectoris will surge at over 3.6% CAGR by the end of 2028, estimates FMI.
Increasing prevalence of coronary heart disease have surged the cases of angina pectoris/chest pain, especially among geriatric population. As per World Health Organization, nearly 17 million succumbed to cardiovascular diseases in 2019. Out of which, around 20% were diagnosed with angina pectoris.
Also, with increasing consumption of unhealthy food products, cases of angina pectoris have burgeoned among millennials. Hence, in order to cater to the growing patient pool, demand for cardiac biomarker diagnostic test kits is expected to increase.
Why is Demand for Cardiac Biomarker Diagnostic Test Kits Surging in Diagnostic Laboratories?
As per Future Market Insights, in terms of end users, the diagnostic laboratories segment is expected to dominate the market. With growing prevalence of cardiovascular diseases, patient pool in diagnostic centers has surged over the years for the diagnosis of cardiovascular diseases.
Hence, demand for cardio biomarker diagnostic test kits is expected to increase within diagnostic laboratories. As per the study, revenue from the diagnostic laboratories segment is expected to reach US$ 997.4 Mn, with the segment exhibiting growth at 5.9% CAGR by the end of 2028.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Cardiac Biomarker Diagnostic Test Kits Market - Competitive Landscape
As per FMI, the global cardiac biomarker diagnostic test kit market is expected to be fragmented in nature. Top 6 players are expected to dominate the market, accounting for nearly 75% of total market share.
Leading players are focusing on strategic collaborations with universities and manufacturers to gain competitive edge. Some of the players are also introducing new products and investing heavily in research and development to develop advanced cardiac biomarkers to cater to growing demand.
For instance,
- In April 2021, Roche announced the launch of a series of five new intended uses for two key cardiac biomarkers using the Elecsys® technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These biomarkers assist in supporting cardiovascular disease management and can help clinicians diagnose heart attacks to manage heart failure.
- In October 2021, Baxter International Inc., a global leader in acute care, joined hands with bioMérieux, a global leader in in vitro diagnostics, to launch the CE marking of the NEPHROCLEAR™ CCL14 Test.
Cardiac Biomarker Diagnostic Test Kits Market - Scope of Report
|
Attribute |
Details |
|
Cardiac Biomarker Diagnostic Test Kits Market Forecast Period |
2021-2028 |
|
Cardiac Biomarker Diagnostic Test Kits Market Historical Data Available for |
2016-2020 |
|
Cardiac Biomarker Diagnostic Test Kits Market Analysis |
US$ Bn for Value |
|
Key Regions Covered |
North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and MEA |
|
Cardiac Biomarker Diagnostic Test Kits Market Key Countries Covered |
United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others. |
|
Key Market Segments Covered |
Product Type, Indication, End User, and Region |
|
Cardiac Biomarker Diagnostic Test Kits Market Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Cardiac Biomarker Diagnostic Test Kits Market by Category
By Product Type:
- Brain Natriuretic Peptide (BNPs) Test Kits
- Creatine Kinase MB (CK-MB) Test Kits
- Troponin (I&T) Tests Kits
- Myoglobin Test Kits
- Other test kits.
By Indication:
- Angina Pectoris
- Acute Myocardial Infarction
- Congestive Heart Failure
- Others.
By End User:
- Hospitals
- Diagnostic Laboratories
- Outpatient Clinics
- Academic & Research Institutes
By Region
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific excluding Japan (APEJ)
- Middle East & Africa
- Japan
Frequently Asked Questions
What is the current value of the global cardiac biomarker diagnostic test kits market?
The global cardiac biomarker diagnostic test kits market is expected to reach a valuation around US$ 1.8 Bn in 2021.
What are the key trends boosting cardiac biomarker diagnostic test kits sales?
Growing prevalence of cardiac diseases, heart failures, and increasing demand for cardiac biomarkers will fuel the sales in the market.
What is the total share of top players operating in the global cardiac biomarker diagnostic test kits market?
Top 6 players in the global cardiac biomarker diagnostic test kits market are expected to hold around ~75% of the total market share.
Which are the major countries driving demand for cardiac biomarker diagnostic test kits?
As per Future Market Insights, India, Germany, the U.S., the U.K., and China are the top countries driving the demand for cardiac biomarker diagnostic test kits.
What is the North America cardiac biomarker diagnostic test kits market outlook?
North America cardiac biomarker diagnostics test kit market is expected to account for 33% of global sales.
Table of Content
1. Executive Summary 1.1. Market Overview 1.2. Market Analysis 1.3. FMI Analysis and Recommendations 1.4. Wheel of Fortune 2. Market Introduction 2.1. Market Taxonomy 2.2. Market Definition 2.3. Exclusion and Inclusion 3. Global Economic Outlook 3.1. Gross Domestic Product by Region & Country, 2021 - 2028 3.2. Global Healthcare Market Indicators 4. Market Dynamics 4.1. Macro-Economic Factors 4.2. Opportunity Analysis 4.3. Drivers 4.3.1. Supply Side Drivers 4.3.2. Demand Side Drivers 4.4. Restraints 4.5. Trends 5. Key Inclusion 5.1. List of Manufacturer and Supplier 5.2. Key Regulation 5.3. Reimbursement Scenario 5.4. Disease Epidemiology 5.5. Pricing Analysis 6. North America Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028 6.1. Introduction 6.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 6.2.1. U.S. 6.2.2. Canada 6.3. Market Size (US$ Mn) Forecast By Country, 2021-2028 6.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021 6.4.1. Troponin Test Kits 6.4.2. CK-MB Test Kits 6.4.3. Myoglobin Test Kits 6.4.4. BNP Test Kit 6.4.5. Others 6.5. Market Size (US$ Mn) Forecast By Product Type, 2021-2028 6.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021 6.6.1. Angina Pectoris 6.6.2. Myocardial Infarction 6.6.3. Congestive Heart Failure 6.6.4. Others 6.7. Market Size (US$ Mn) Forecast By Indication, 2021-2028 6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 6.8.1. Diagnostic Laboratories 6.8.2. Outpatient Clinics 6.8.3. Academic and Research Institutes 6.8.4. Hospitals 6.9. Market Size (US$ Mn) Forecast By End User, 2021-2028 6.10. Market Attractiveness Analysis 6.10.1. By Country 6.10.2. By Product Type 6.10.3. By Indication 6.10.4. By End User 6.11. Drivers and Restraints: Impact Analysis 6.12. Key Market Participants - Intensity Mapping 7. Latin America Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028 7.1. Introduction 7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 7.2.1. Brazil 7.2.2. Mexico 7.2.3. Argentina 7.2.4. Rest of Latin America 7.3. Market Size (US$ Mn) Forecast By Country, 2021-2028 7.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021 7.4.1. Troponin Test Kits 7.4.2. CK-MB Test Kits 7.4.3. Myoglobin Test Kits 7.4.4. BNP Test Kit 7.4.5. Others 7.5. Market Size (US$ Mn) Forecast By Product Type, 2021-2028 7.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021 7.6.1. Angina Pectoris 7.6.2. Myocardial Infarction 7.6.3. Congestive Heart Failure 7.6.4. Others 7.7. Market Size (US$ Mn) Forecast By Indication, 2021-2028 7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 7.8.1. Diagnostic Laboratories 7.8.2. Outpatient Clinics 7.8.3. Academic and Research Institutes 7.8.4. Hospitals 7.9. Market Size (US$ Mn) Forecast By End User, 2021-2028 7.10. Market Attractiveness Analysis 7.10.1. By Country 7.10.2. By Product Type 7.10.3. By Indication 7.10.4. By End User 7.11. Drivers and Restraints: Impact Analysis 7.12. Key Market Participants - Intensity Mapping 8. Western Europe Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028 8.1. Introduction 8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 8.2.1. Germany 8.2.2. U.K. 8.2.3. France 8.2.4. Italy 8.2.5. Spain 8.2.6. Rest of Western Europe 8.3. Market Size (US$ Mn) Forecast By Country, 2021-2028 8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021 8.4.1. Troponin Test Kits 8.4.2. CK-MB Test Kits 8.4.3. Myoglobin Test Kits 8.4.4. BNP Test Kit 8.4.5. Others 8.5. Market Size (US$ Mn) Forecast By Product Type, 2021-2028 8.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021 8.6.1. Angina Pectoris 8.6.2. Myocardial Infarction 8.6.3. Congestive Heart Failure 8.6.4. Others 8.7. Market Size (US$ Mn) Forecast By Indication, 2021-2028 8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 8.8.1. Diagnostic Laboratories 8.8.2. Outpatient Clinics 8.8.3. Academic and Research Institutes 8.8.4. Hospitals 8.9. Market Size (US$ Mn) Forecast By End User, 2021-2028 8.10. Market Attractiveness Analysis 8.10.1. By Country 8.10.2. By Product Type 8.10.3. By Indication 8.10.4. By End User 8.11. Drivers and Restraints: Impact Analysis 8.12. Key Market Participants - Intensity Mapping 9. Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028 9.1. Introduction 9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 9.2.1. Russia 9.2.2. Poland 9.2.3. Rest of Eastern Europe 9.3. Market Size (US$ Mn) Forecast By Country, 2021-2028 9.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021 9.4.1. Troponin Test Kits 9.4.2. CK-MB Test Kits 9.4.3. Myoglobin Test Kits 9.4.4. BNP Test Kit 9.4.5. Others 9.5. Market Size (US$ Mn) Forecast By Product Type, 2021-2028 9.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021 9.6.1. Angina Pectoris 9.6.2. Myocardial Infarction 9.6.3. Congestive Heart Failure 9.6.4. Others 9.7. Market Size (US$ Mn) Forecast By Indication, 2021-2028 9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 9.8.1. Diagnostic Laboratories 9.8.2. Outpatient Clinics 9.8.3. Academic and Research Institutes 9.8.4. Hospitals 9.9. Market Size (US$ Mn) Forecast By End User, 2021-2028 9.10. Market Attractiveness Analysis 9.10.1. By Country 9.10.2. By Product Type 9.10.3. By Indication 9.10.4. By End User 9.11. Drivers and Restraints: Impact Analysis 9.12. Key Market Participants - Intensity Mapping 10. Asia Pacific Excluding China & Japan Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 10.2.1. India 10.2.2. Australia and New Zealand 10.2.3. ASEAN 10.2.4. Rest of APECJ 10.3. Market Size (US$ Mn) Forecast By Country, 2021-2028 10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021 10.4.1. Troponin Test Kits 10.4.2. CK-MB Test Kits 10.4.3. Myoglobin Test Kits 10.4.4. BNP Test Kit 10.4.5. Others 10.5. Market Size (US$ Mn) Forecast By Product Type, 2021-2028 10.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021 10.6.1. Angina Pectoris 10.6.2. Myocardial Infarction 10.6.3. Congestive Heart Failure 10.6.4. Others 10.7. Market Size (US$ Mn) Forecast By Indication, 2021-2028 10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 10.8.1. Diagnostic Laboratories 10.8.2. Outpatient Clinics 10.8.3. Academic and Research Institutes 10.8.4. Hospitals 10.9. Market Size (US$ Mn) Forecast By End User, 2021-2028 10.10. Market Attractiveness Analysis 10.10.1. By Country 10.10.2. By Product Type 10.10.3. By Indication 10.10.4. By End User 10.11. Drivers and Restraints: Impact Analysis 10.12. Key Market Participants - Intensity Mapping 11. China Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021 11.2.1. Troponin Test Kits 11.2.2. CK-MB Test Kits 11.2.3. Myoglobin Test Kits 11.2.4. BNP Test Kit 11.2.5. Others 11.3. Market Size (US$ Mn) Forecast By Product Type, 2021-2028 11.4. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021 11.4.1. Angina Pectoris 11.4.2. Myocardial Infarction 11.4.3. Congestive Heart Failure 11.4.4. Others 11.5. Market Size (US$ Mn) Forecast By Indication, 2021-2028 11.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 11.6.1. Diagnostic Laboratories 11.6.2. Outpatient Clinics 11.6.3. Academic and Research Institutes 11.6.4. Hospitals 11.7. Market Size (US$ Mn) Forecast By End User, 2021-2028 11.8. Market Attractiveness Analysis 11.8.1. By Product Type 11.8.2. By Indication 11.8.3. By End User 11.9. Drivers and Restraints: Impact Analysis 11.10. Key Market Participants - Intensity Mapping 12. Middle East and Africa Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 12.2.1. GCC Countries 12.2.2. South Africa 12.2.3. Rest of Middle East and Africa 12.3. Market Size (US$ Mn) Forecast By Country, 2021-2028 12.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2021 12.4.1. Troponin Test Kits 12.4.2. CK-MB Test Kits 12.4.3. Myoglobin Test Kits 12.4.4. BNP Test Kit 12.4.5. Others 12.5. Market Size (US$ Mn) Forecast By Product Type, 2021-2028 12.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2021 12.6.1. Angina Pectoris 12.6.2. Myocardial Infarction 12.6.3. Congestive Heart Failure 12.6.4. Others 12.7. Market Size (US$ Mn) Forecast By Indication, 2021-2028 12.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 12.8.1. Diagnostic Laboratories 12.8.2. Outpatient Clinics 12.8.3. Academic and Research Institutes 12.8.4. Hospitals 12.9. Market Size (US$ Mn) Forecast By End User, 2021-2028 12.10. Market Attractiveness Analysis 12.10.1. By Country 12.10.2. By Product Type 12.10.3. By Indication 12.10.4. By End User 12.11. Drivers and Restraints: Impact Analysis 12.12. Key Market Participants - Intensity Mapping 13. Forecast Factors: Relevance and Impact 14. Forecast Assumptions 15. Market Structure Analysis 15.1. Market Structure by Tier 15.2. Market Share Analysis (2017) for Top Players, By Region 16. Competition Analysis 16.1. Competition Dashboard 16.2. Competitors Deep Dive 16.2.1. Abbott Laboratories 16.2.2. Hoffmann-La Roche AG 16.2.3. Bio-Rad Laboratories 16.2.4. Danaher Corporation 16.2.5. Seimens Healthineers 16.2.6. Thermofisher Scientific 16.2.7. Becton, Dickinson and Company 16.2.8. bioMérieux 16.2.9. Randox Laboratories Ltd. 17. Global Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028 By Region 17.1. Introduction / Key Findings 17.2. Historical Market Size (US$ Mn) Analysis By Region 17.2.1. North America 17.2.2. Latin America 17.2.3. Western Europe 17.2.4. Eastern Europe 17.2.5. Asia Pacific Excluding Japan And China 17.2.6. China 17.2.7. Japan 17.2.8. Middle East and Africa 17.3. Market Size (US$ Mn) Forecast By Region 17.4. Market Attractiveness Analysis By Region 18. Global Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028, By Product Type 18.1. Introduction/Key Finding 18.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2013-2021 18.2.1. Troponin Test Kits 18.2.2. CK-MB Test Kits 18.2.3. Myoglobin Test Kits 18.2.4. BNP Test Kit 18.2.5. Others 18.3. Market Size (US$ Mn) Forecast By Product Type, 2021-2028 18.4. Market Attractiveness Analysis By Product Type 19. Global Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028, By Indication 19.1. Introduction/Key Finding 19.2. Historical Market Size (US$ Mn) Analysis By Indication, 2013-2021 19.2.1. Angina Pectoris 19.2.2. Myocardial Infarction 19.2.3. Congestive Heart Failure 19.2.4. Others 19.3. Market Size (US$ Mn) Forecast By Indication, 2021-2028 19.4. Market Attractiveness Analysis By Indication 20. Global Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028, By End User 20.1. Introduction/Key Finding 20.2. Historical Market Size (US$ Mn) Analysis By End User, 2013-2021 20.2.1. Diagnostic Laboratories 20.2.2. Outpatient Clinics 20.2.3. Academic and Research Institutes 20.2.4. Hospitals 20.3. Market Size (US$ Mn) Forecast By End User, 2021-2028 20.4. Market Attractiveness Analysis By End User 21. Global Cardiac Biomarker Diagnostic Test Kits Market Analysis 2013-2021 and Forecast 2021-2028 21.1. Market Value Analysis (US$ Mn) 21.2. Absolute $ Opportunity 22. Assumptions and Acronyms Used 23. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Expenditure on Health, (% of GDP), by Country, 2021 – 2028 (1/2) Table 2: CPT code for Cardiac Biomarker Table 3: CPT code for Cardiac Biomarker with reimburse limit amounts Table 4: Epidemiology of Cardiovascular Diseases in different countries (2021) (1/2) Table 5: Epidemiology of Cardiovascular Diseases in different countries (2021) (2/2) Table 6: North America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Country Table 7: North America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type Table 8: North America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication Table 9: North America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User Table 10: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Country Table 11: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type Table 12: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication Table 13: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User Table 14: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Country Table 15: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type Table 16: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication Table 17: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User Table 18: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Country Table 19: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type Table 20: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication Table 21: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User Table 22: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Country Table 23: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type Table 24: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication Table 25: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User Table 26: China Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type Table 27: China Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication Table 28: China Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User Table 29: Japan Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type Table 30: Japan Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication Table 31: Japan Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User Table 32: MEA Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Country Table 33: MEA Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Product Type Table 34: MEA Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By Indication Table 35: MEA Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis 2013-2021 and Forecast 2021–2028, By End User Table 36: Global Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis- and Opportunity Assessment 2021–2028, By Region Table 37: Global Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis- and Opportunity Assessment 2021–2028, By Product Type Table 38: Global Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis- and Opportunity Assessment 2021–2028, By Indication Table 39: Global Cardiac Biomarker Diagnostic Test Kits Market Value (US$ Mn) Analysis- and Opportunity Assessment 2021–2028, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: North America Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E) Figure 02: North America Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E) Figure 03: North America Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E) Figure 04: North America Cardiac Biomarker Diagnostic Test Kits Market Value Share By Country (2021 E) Figure 05: North America Cardiac Biomarker Diagnostic Test Kits Market Value Analysis Figure 06: North America Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 07: U.S. Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021 Figure 08: U.S. Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 09: Canada Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), Figure 10: Canada Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 11: North America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028 Figure 12: North America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028 Figure 13: North America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028 Figure 14: North America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Country, 2021-2028 Figure 15: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E) Figure 16: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E) Figure 17: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E) Figure 18: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Share By Country (2021 E) Figure 19: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Analysis Figure 20: Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 21: Brazil Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021 Figure 22: Brazil Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 23: Mexico Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), Figure 24: Mexico Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 25: Argentina Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021 Figure 26: Argentina Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 27: Rest of Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), Figure 28: Rest of Latin America Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 29: Latin America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028 Figure 30: Latin America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028 Figure 31: Latin America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028 Figure 32: Latin America Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Country, 2021-2028 Figure 33: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E) Figure 34: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E) Figure 35: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E) Figure 36: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By Country (2021 E) Figure 37: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Analysis Figure 38: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 39: U.K. Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021 Figure 40: U.K. Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 41: Germany Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), Figure 42: Germany Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 43: France Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021 Figure 44: France Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 45: Italy Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), Figure 46: Italy Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 47: Spain Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021 Figure 48: Spain Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 49: Rest of Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), Figure 50: Rest of Western Europe Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 51: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028 Figure 52: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028 Figure 53: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028 Figure 54: Western Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Country, 2021-2028 Figure 55: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E) Figure 56: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E) Figure 57: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E) Figure 58: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Share By Country (2021 E) Figure 59: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Analysis Figure 60: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 61: Russia Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021 Figure 62: Russia Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 63: Poland Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), Figure 64: Poland Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 65: Rest of Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021 Figure 66: Rest of Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 67: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028 Figure 68: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028 Figure 69: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028 Figure 70: Eastern Europe Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Country, 2021-2028 Figure 71: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E) Figure 72: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E) Figure 73: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E) Figure 74: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Share By Country (2021 E) Figure 75: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Analysis Figure 76: APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 77: India Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021 Figure 78: India Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 79: Australia & NZ Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), Figure 80: Australia & NZ Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 81: ASEAN Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021 Figure 82: ASEAN Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 83: Rest of APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), Figure 84: Rest of APECJ Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 85: APECJ Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028 Figure 86: APECJ Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028 Figure 87: APECJ Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028 Figure 88: APECJ Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Country, 2021-2028 Figure 89: China Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E) Figure 90: China Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E) Figure 91: China Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E) Figure 92: China Cardiac Biomarker Diagnostic Test Kits Market Value Analysis Figure 93: China Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 94: China Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028 Figure 95: China Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028 Figure 96: China Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028 Figure 97: Japan Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E) Figure 98: Japan Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E) Figure 99: Japan Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E) Figure 100: Japan Cardiac Biomarker Diagnostic Test Kits Market Value Analysis Figure 101: Japan Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 102: Japan Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028 Figure 103: Japan Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028 Figure 104: Japan Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028 Figure 105: MEA Cardiac Biomarker Diagnostic Test Kits Market Value Share By Product Type (2021 E) Figure 106: MEA Cardiac Biomarker Diagnostic Test Kits Market Value Share By Indication (2021 E) Figure 107: MEA Cardiac Biomarker Diagnostic Test Kits Market Value Share By End User (2021 E) Figure 108: MEA Cardiac Biomarker Diagnostic Test Kits Market Value Share By Country (2021 E) Figure 109: MEA Cardiac Biomarker Diagnostic Test Kits Market Value Analysis Figure 110: MEA Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 111: South Africa Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021 Figure 112: South Africa Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 113: GCC Countries Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), Figure 114: GCC Countries Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 115: Rest of MEA Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021 Figure 116: Rest of MEA Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), 2021-2028 Figure 117: MEA Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028 Figure 118: MEA Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028 Figure 119: MEA Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028 Figure 120: MEA Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Country, 2021-2028 Figure 121: Global Cardiac Biomarker Diagnostic Test Kits Market: Company Share Analysis (2021) Figure 122: Global Cardiac Biomarker Diagnostic Test Kits Market Share Analysis (%), By Region, 2018 & 2028 Figure 123: Global Cardiac Biomarker Diagnostic Test Kits Market Y-o-Y Analysis (%), By Region, 2021-2028 Figure 124: Global Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Region, 2021-2028 Figure 125: Global Cardiac Biomarker Diagnostic Test Kits Market Share Analysis (%), By Product Type, 2018 & 2028 Figure 126: Global Cardiac Biomarker Diagnostic Test Kits Market Y-o-Y Analysis (%), By Product Type, 2021-2028 Figure 127: Global Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Product Type, 2021-2028 Figure 128: Global Cardiac Biomarker Diagnostic Test Kits Market Share Analysis (%), By Indication, 2018 & 2028 Figure 129: Global Cardiac Biomarker Diagnostic Test Kits Market Y-o-Y Analysis (%), By Indication, 2021-2028 Figure 130: Global Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by Indication, 2021-2028 Figure 131: Global Cardiac Biomarker Diagnostic Test Kits Market Share Analysis (%), By End User, 2018 & 2028 Figure 132: Global Cardiac Biomarker Diagnostic Test Kits Market Y-o-Y Analysis (%), By End User, 2021-2028 Figure 133: Global Cardiac Biomarker Diagnostic Test Kits Market Attractiveness Analysis by End User, 2021-2028 Figure 134: Global Cardiac Biomarker Diagnostic Test Kits Market Value Analysis (US$ Mn), 2013-2021 Figure 135: Global Cardiac Biomarker Diagnostic Test Kits Market Value Forecast (US$ Mn), Figure 136: Global Cardiac Biomarker Diagnostic Test Kits Market Absolute $ Opportunity, 2018 - 2028
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
